Navigation Links
LA BioMed researcher honored for excellence in education
Date:6/9/2009

LOS ANGELES (June 9, 2009) Carl D. Stevens, MD, MPH, a researcher at Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed), recently received the Award for Excellence in Education from UCLA.

The David Geffen School of Medicine at the University of California, Los Angeles (UCLA) established the honor to "recognize outstanding dedication, innovation and sustained excellence in education."

Dr. Stevens is a clinical professor of medicine, director of curriculum development and director of combined degree programs at the David Geffen School of Medicine at UCLA. He serves as director of Quality and Process Improvement and as an attending physician in the Department of Emergency Medicine at Harbor-UCLA Medical Center.

"Congratulations to Dr. Stevens on this well-deserved honor for his many contributions to education," said LA BioMed President and CEO Carole Wagner Vallianos, Esq. "He has been a leader in the field, and he serves as an outstanding example of the high caliber of researchers and faculty at LA BioMed. We are proud of his many accomplishments."


'/>"/>

Contact: Laura Mecoy
LMecoy@issuesmanagement.com
310-546-5860
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed)
Source:Eurekalert  

Page: 1

Related medicine news :

1. Entest BioMedical Inc. Adds Former National Cancer Institute Researcher to Scientific Advisory Board With Focus on Stem Cell Cancer Patient Therapies
2. LA BioMed researcher receives clinical teaching award
3. New Video Series Spotlights Role of Biomedical Engineers in Caring for Total Artificial Heart Patients
4. Response Biomedical Closes $12.65 million Unit Offering
5. LA BioMed Vice President named champion of immunization
6. Garth Fisher, M.D., F.A.C.S., World Renowned Plastic Surgeon and Co-Founder Of CellCeuticals(R) Biomedical Skin Treatments Revealed On E!s Keeping Up With The Kardashians as the Surgeon Behind Bruce Jenners New Face
7. Alpine Biomed Corporation to Integrate Bravo pH Monitoring With GastroTrac Software to Enhance Gastrodiagnostic Testing Capabilities
8. BioMed Realty Trust Prices Public Offering of 16,000,000 Shares of Common Stock
9. BioMed Realty Trust Announces Public Offering of 14,000,000 Shares of Common Stock
10. Response Biomedical Announces Proposed Unit Offering
11. BioMed Realty Trust Reports First Quarter 2009 Operating and Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
LA BioMed researcher honored for excellence in education
(Date:4/29/2016)... ... April 30, 2016 , ... World Patent Marketing ... Up Springboard, an automotive invention that improves the storage features of a pick ... billion," says Scott Cooper, CEO and Creative Director of World Patent Marketing. "Over ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... , announces the addition Onnit brand Alpha BRAIN and New Mood Daily-Stress Formula ... brain and mood optimization products to the store is just one more way ...
(Date:4/29/2016)... ... April 29, 2016 , ... The White House announced ... loans, more information about their loan terms and accounts, and more protections for ... including federal and private loans, has reached $1.3 trillion, with 43 million Americans ...
(Date:4/29/2016)... ... April 29, 2016 , ... The Wharton ... $30,000 Perlman Grand Prize of the 2016 Wharton Business Plan Competition —as ... People’s Choice Award, and the Committee Award for Most ‘Wow Factor,’ making them ...
(Date:4/29/2016)... ... April 29, 2016 , ... Dr. Robert Mondavi, one of the ... smiles. Cosmetic dentistry is a fast-growing field as more patients are discovering the many ... learn more about the options currently available to them and which ones might work ...
Breaking Medicine News(10 mins):
(Date:4/27/2016)... Oasmia Pharmaceutical AB (NASDAQ: ... new generation of drugs within human and veterinary ... Paclical/Apealea in the Phase III study that included ... cancer. These preliminary results showed non-inferiority between the ... versus Taxol in combination with carboplatin. In fact, ...
(Date:4/27/2016)... At the Sachs CEO forum ... Phase 2 clinical study of its lead drug candidate, ... implantation (CI) surgery. This large, placebo-controlled, double-blind, phase 2 ... and France . STR001 ... time of surgery. "Despite advances in cochlear implant technology, ...
(Date:4/26/2016)... April 26, 2016 US demand for ... expand 4.9 percent annually to $27.6 billion in ... facilities to decrease rates of healthcare-associated infections (HAIs) ... equipment, and services.  Although declining, the overall rate ... targeted levels set by the CDC.  Recent statistics ...
Breaking Medicine Technology: